Gensight Biologics SA

NEW
XPAR:SIGHT (France)  
€ 0.085 +0.00010 (+0.12%) Aug 12
At Loss
Market Cap:
€ 19.86M ($ 22.91M)
Enterprise V:
€ 30.31M ($ 34.96M)
Volume:
474.35K
Avg Vol (2M):
456.31K
Trade In:
Volume:
474.35K
At Loss

Gensight Biologics SA (XPAR:SIGHT) Dividend

Gensight Biologics SA (XPAR:SIGHT) does not currently pay a regular dividend. Over the past 3 years it has returned capital to shareholders via buybacks at a rate of -68.3%. View its historical dividend record below and compare with dividend-paying peers.

Frequently Asked Questions: XPAR:SIGHT Dividend

Does Gensight Biologics SA (XPAR:SIGHT) pay a dividend?

Gensight Biologics SA (XPAR:SIGHT) does not currently pay a regular dividend. Review the historical record above for any past dividend payments or capital return policies.

Why doesn't Gensight Biologics SA pay a dividend?

Companies typically forgo dividends to reinvest earnings into growth, R&D, acquisitions, or share buybacks. Gensight Biologics SA has returned capital to shareholders via buybacks at a rate of -68.3% over the past 3 years.

What are dividend-paying alternatives to Gensight Biologics SA?

For dividend-paying alternatives in Gensight Biologics SA's sector, view dividend stocks by industry on GuruFocus's dividend stock screener.